Repeat cytoreductive surgery with or without intraperitoneal chemotherapy for recurrent epithelial appendiceal neoplasms

BACKGROUND: With recurrence rates after primary cytoreductive surgery (CRS) in excess of 50 per cent, repeat CRS is being performed increasingly, but survival outcomes have not been reported widely. This study examined the outcomes following repeat CRS for appendiceal cancer with peritoneal surface...

Descripción completa

Detalles Bibliográficos
Autores principales: Karpes, J. B., Lansom, J. D., Alshahrani, M., Parikh, R., Shamavonian, R., Alzahrani, N. A., Liauw, W., Morris, D. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260401/
https://www.ncbi.nlm.nih.gov/pubmed/32020757
http://dx.doi.org/10.1002/bjs5.50262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260401/
https://www.ncbi.nlm.nih.gov/pubmed/32020757
http://dx.doi.org/10.1002/bjs5.50262

Ejemplares similares